All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer's type

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 38-46

  Sodhi, Rupinder K ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

All trans retinoic acid; Alzheimer's disease; Dementia; Morris water maze; Vitamin A

Indexed keywords

ACETYLCHOLINESTERASE; CHOLESTEROL; GLUTATHIONE; MYELOPEROXIDASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; DEMENTIA; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; STREPTOZOTOCIN INDUCED DEMENTIA;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DEMENTIA; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; PEROXIDASE; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; THIOBARBITURATES; TRETINOIN;

EID: 84867902245     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.09.012     Document Type: Article

References (48)

1. Ahlemeyer B., Krieglstein J. Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis. Neurochem Int 2000, 36:1-5.
2. Allain C.C., Pool L.S., Chan C.S., Richmond W., Paul C.F. Enzymatic determination of total serum cholesterol. Clin Chem 1974, 20:470-475.
3. Banchroft A.S., Turner D.R. Theory and practice of histological techniques 1996, Churchill Livingstone, New York. Fourth ed.
4. Barone F., Hillegrass L., Price W., White E., Lee G., Feuerstein H., et al. Polymorphonuclear leucocytes infiltration into cerebral focal ischemia tissue: myeloperoxide activity assay and histological verification. J Neurol Res 1991, 29:336-345.
5. Beutler E., Duron O., Kelly B. Reduced glutathione estimation. J Lab Clin Med 1963, 61:82-86.
6. Bonet M.L., Ribot J., Felipe F., Palou A. Vitamin A and the regulation of fat reserves. Cell Mol Life Sci 2003, 60:1311-1321.
7. Carta M., Stancampiano R., Tronci E., Collu M., Usiello A., Morelli M., et al. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neurosci 2006, 139:1163-1172.
8. Chen J., Costa L.G., Guizzetti M. Retinoic acid isomers up-regulate ATP binding cassette a1 and g1 and cholesterol efflux in rat astrocytes: implications for their therapeutic and teratogenic effects. J Pharmacol Exp Ther 2011, 338(3):870-878.
9. Chiang M.Y., Misner D., Kempermann G., Schikorski T., Giguère V., Sucov H.M., et al. An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 1998, 21:1353-1361.
10. Cocco S., Diaz G., Stancampiano R., Diana A., Carta M., Curreli R., et al. Vitamin A deficiency produces spatial learning and memory impairment in rats. Neurosci 2002, 115:475-482.
11. Ding Y., Qiao A., Wang Z., Goodwin J.S., Lee E.S., Block M.L., et al. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 2008, 28:11622-11634.
12. Ellis J.M. Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 2005, 105:145-158.
13. Ellman G.L., Courtney D.K., Andres V., Feathstone R.M. A new and rapid colorimetric determination of acetylcholinestrase activity. Biochem Pharmacol 1961, 7:88-95.
14. Germain P. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 2006, 58:712-725.
15. Goodman A.B. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. J Cell Physiol 2006, 209:598-603.
16. Grant W.B. Dietary links to Alzheimer's disease: 1999 update. J Alzheimers Dis 1991, 1:197-201.
17. Green P.S., Mendez A., Jacob J.S., Crowley J.R., Growdon W., Hyman B.T., et al. Neuronal expression of myeloperoxidase is increased in Alzheimers disease. J Neurochem 2004, 90:724-733.
18. Guo J.M., Xiao B.X., Lou Y.R., Wang D.H., Yan C.H., Zhan L., et al. The effects of all-transretinoic acid on cell cycle and alkaline phosphatase activity in pancreatic cancer cells. Med Chem 2006, 2:457-461.
19. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late onset sporadic Alzheimer disease. A mini review. J Neural Transm 2000, 109:341-360.
20. Ishrat T., Khan M.B., Hoda M.N., Yousaf S., Ahmad M., Ansari M.A., et al. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 2006, 171:9-16.
21. Kane M.A., Folias A.E., Wang C., Napoli J.L., et al. Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal Chem 2008, 80:1702-1708.
22. Kaur B., Singh N., Jaggi A.S. Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia. Fundam Clin Pharmacol 2009, 23:557-566.
23. Kim B.H., Kang K.S., Lee Y.S. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE (2) release from mouse peritoneal macrophages and TNF-alpha release from rat peripheral blood mononuclear cells. Toxicol Lett 2004, 150:191-201.
24. Kiningham K.K., Cardozo Z.A., Cook C., Cole M.P., Stewart J.C., Tassone M., et al. All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-kappaB. Free Radic Biol Med 2008, 44:1610-1616.
25. Lee H.P., Casadesus G., Zhu X., Lee H.G., Perry G., Smith M.A., et al. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev Neurother 2009, 9:1615-1621.
26. Lester-Coll N., Rivera E.J., Soscia S.J., Doiron K., Wands J.R., de la Monte S.M. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J Alzheimers Dis 2006, 9:13-33.
27. Li L., Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007, 56:384-402.
28. Lolic R., Silbergleit G., Fiskume, Rosenthal R.E. Neuroprotective effects of hyperbaric oxygen treatment in experimental focal ischemia are associated with reduced brain leucocyte myeloperoxidase activity. Brain Res 2003, 971:90-94.
29. Lowry O.H., Rosebrough N.J., Far A.L., Randall R.J. Protein measurement with folin-phenol reagent. J Biol Chem 1951, 193:265-275.
30. Lu J., Zhang F., Zhao D., Hong L., Min J., Zhang L., et al. ATRA-inhibited proliferation in glioma cells is associated with subcellular redistribution of beta-catenin via upregulation of Axin. J Neurooncol 2008, 87:271-277.
31. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
32. Mey J. Retinoic acid as a regulator of cytokine signaling after nerve injury. Z Naturforsch 2001, 56:163-176.
33. Morris R. Development of a water maze producer for studying spatial learning in rats. J Neurosci Methods 1984, 11:47-60.
34. Muley P.D., McNeill E.M., Marzinke M.A., Knobel K.M., Barr M.M., Clagett-Dame M. The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation. Dev Neurobiol 2008, 68:1441-1453.
35. Ohokawa H., Ohishi N., Yagi K. Assay of lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
36. Perl D.P. Neuropathology of Alzheimer's disease. Mt Sinai J Med 2010, 77:32-42.
37. Puchtler H., Sweat F., Levine M. On binding of Congo red amyloid. J Histochem Cytochem 1962, 10:355-364.
38. Salkovic-Petrisic M., Osmanovic-Barilar J., Brückner M.K., Hoyer S., Arendt T., Riederer P. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm 2011, 118:765-772.
39. Sharma B., Singh N. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacol (Berl) 2011, 215:677-687.
40. Sharma B., Singh N., Singh M. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil. J Psychopharmacol 2008, 22:162-171.
41. Swift C.B., Hays J.L., Petty W.J. Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapy. Endocr Metab Immune Disord Drug Targets 2008, 8:47-50.
42. Tafti M., Ghyselinck N.B. Functional implication of the vitamin A signaling pathway in the brain. Arch Neurol 2007, 64:1706-1711.
43. Tahirovic I., Sofic E., Sapcanin A., Gavrankapetanovic L., Bach-Rojecky, Salkovic P.M., et al. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimers disease and diabetes mellitus. Neurochem Res 2007, 32:1709-1717.
44. Tsai F.M., Shyu R.Y., Lin S.C., Wu C.C., Jiang S.Y. Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells. BMC Cell Biol 2009, 10-15.
45. Villarroya F., Iglesias R., Giralt M. Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. Curr Med Chem 2004, 11:795-805.
46. Voss G., Sachsse K. Red cell and plasma cholinesterase activities in micro samples of human and animal blood determined simultaneously by a modified acetylcholine/DNTB procedure. Toxicol App Pharmacol 1970, 16:764-772.
47. Yamasaki T., Muranaka H., Kaseda Y., Mimori Y., Tobimatsu S. Understanding the pathophysiology of Alzheimer's disease and mild cognitive impairment: a mini review on fMRI and ERP studies. Neurol Res Int 2012, 9:719056-719061.
48. Ziouzenkova O., Plutzky J. Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett 2008, 582:32-38.